Anidulafungin-13C6
Anidulafungin-13C6 (LY303366-13C6) is 13C labeled Anidulafungin. Anidulafungin is a new semisynthetic echinocandin with antifungal potency.
Product Specifications
Product Name Alternative
LY303366-13C6
UNSPSC
12352005
Target
Antibiotic; Fungal; Isotope-Labeled Compounds
Related Pathways
Anti-infection; Others
Applications
COVID-19-immunoregulation
Field of Research
Infection; Cancer
Smiles
O[C@@H]1C[C@@H](C(N[C@H](C(N[C@H](C(N2[C@H](C(N[C@@H]([C@@H](C[C@@H](C(N[C@H](C3=O)[C@@H](C)O)=O)NC([13C]4=[13CH][13CH]=[13C]([13CH]=[13CH]4)C5=CC=C(C=C5)C6=CC=C(C=C6)OCCCCC)=O)O)O)=O)[C@H]([C@H](C2)C)O)=O)[C@H](O)C)=O)[C@@H]([C@H](C7=CC=C(C=C7)O)O)O)=O)N3C1
Molecular Formula
C52 13C6H73N7O17
Molecular Weight
1146.19
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Zhanel GG, et al. In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species. Antimicrob Agents Chemother. 1997 Apr;41 (4) :863-5|[3]Locke JB, et al. Characterization of In Vitro Resistance Development to the Novel Echinocandin CD101 in Candida Species. Antimicrob Agents Chemother. 2016 Sep 23;60 (10) :6100-7.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC402444-100 1x 100 µL
GATA-3 (Breast and Urothelial Marker) (GATA3/2444), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNCB1578-500 1x 500 µL
SREBP1 (SREBP1/1578), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 